BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22691536)

  • 1. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
    Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
    Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
    Batista PA; Fogaça MV; Guimarães FS
    Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
    Fogaça MV; Fedoce AG; Ferreira-Junior NC; Guimarães FS; Resstel LB
    Psychopharmacology (Berl); 2016 Apr; 233(8):1377-85. PubMed ID: 26873081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
    Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
    Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
    Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex.
    Almeida-Santos AF; Moreira FA; Guimaraes FS; Aguiar DC
    J Psychopharmacol; 2017 Jun; 31(6):740-749. PubMed ID: 28440729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
    Moreira FA; Aguiar DC; Guimarães FS
    Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence.
    Lisboa SF; Borges AA; Nejo P; Fassini A; Guimarães FS; Resstel LB
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():76-83. PubMed ID: 25595265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
    Fogaça MV; Reis FM; Campos AC; Guimarães FS
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Umathe SN; Manna SS; Utturwar KS; Jain NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
    Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
    Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
    Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
    Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.
    Fogaça MV; Gomes FV; Moreira FA; Guimarães FS; Aguiar DC
    Psychopharmacology (Berl); 2013 Apr; 226(3):579-87. PubMed ID: 23183551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees.
    Schuelert N; McDougall JJ
    Arthritis Rheum; 2008 Jan; 58(1):145-53. PubMed ID: 18163511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
    Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
    Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB
    Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
    Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.